Regenerative Potential of Spermatogonial Stem Cells, Endothelial Progenitor Cells, and Epithelial Progenitor Cells of C57Bl/6 Male Mice with Metabolic Disorders


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The properties of spermatogonial stem cells, endothelial progenitor cells, and the epithelial progenitors of C57Bl/6 mice under conditions of metabolic disorders were studied using the model of busulfan-induced suppression of spermatogenesis and in vitro culture technique. Spermatogonial stem cells CD117—CD90+ and epithelial progenitors CD45—CD31—Sca-1+CD49f+ derived from the testes of mice with metabolic disturbances demonstrated 17- and 28-fold increase in the respective cell mass and generated cell colonies in vitro. In contrast, spermatogonial stem cells with immune phenotype CD51—CD24+CD52+ had reduced selfrenewal capacity. Spermatogonial stem cells CD117—CD90+ and CD117+CD90+ as well as endothelial progenitors CD45—CD31+ derived from the testes of donor mice with metabolic disorders demonstrated high transplantation capacity in C57Bl/6 mouse testes damaged by cytostatic busulfan.

About the authors

E. G. Skurikhin

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

A. V. Pakhomova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Author for correspondence.
Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

O. V. Pershina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

L. A. Ermolaeva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

V. A. Krupin

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

N. N. Ermakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

E. S. Pan

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

A. I. Kudryashova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

O. Yu. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

T. B. Pavlovskaya

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

N. V. Litvyakov

Tomsk National Research Medical Center, Russian Academy of Sciences

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

V. E. Goldberg

Tomsk National Research Medical Center, Russian Academy of Sciences

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

A. M. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk


Copyright (c) 2016 Springer Science+Business Media, LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies